Contemporary Approaches to In-Transit Melanoma
2018 ◽
Vol 14
(5)
◽
pp. 292-300
◽
Keyword(s):
In-transit melanoma represents a distinct disease pattern of heterogeneous superficial tumors. Many treatments have been developed specifically for this type of disease, including regional chemotherapy and a variety of directly injectable agents. Novel strategies include the intralesional delivery of oncolytic viruses and immunocytokines. The combination of intralesional or regional chemotherapy with systemic immune checkpoint inhibitors also is a promising approach. In the current review, we examine the general management of the workup of patients with in-transit disease, the range of available therapies, and recommendations for specific therapies for an individual patient.
Keyword(s):
2020 ◽
Vol 8
(1)
◽
pp. e000440
◽
Keyword(s):
2020 ◽
Vol 20
(6)
◽
pp. 635-652
◽
2020 ◽
Vol 8
(2)
◽
pp. e000440corr1
2020 ◽
Vol 8
(Suppl 3)
◽
pp. A630-A630
2019 ◽
2016 ◽
Vol 44
(5)
◽
pp. 592-595
◽